|
|
DOUG LONG, Vice President of Industry Relations, IMS HEALTH
Doug has been with IMS HEALTH, the world’s largest pharmaceutical information company offering services to the pharmaceutical industry in over 101 countries around the globe, since 1989. His fundamental task is to help secure data for all existing and new databases supported by IMS HEALTH, manage supplier, manufacturer & association relationships, and develop information for data partners. As direct consequence of his involvement in these areas, Doug has considerable experience with, and a unique perspective on, the changing U.S. and global healthcare marketplace and pharmaceutical distribution.
Although well versed in the global pharmaceutical market, the heart of Doug’s Industry Year in Review is that of trends and forecasts in the US, including up-to-the-minute market news and pharmaceutical innovation. Doug is current on topics such as mergers and acquisitions, tiered co-pay, generics, biologics, PBM’s and other emerging channels, and is also an expert on the complex issue of patient privacy. Wholesalers, retailers, manufacturers, emerging classes of trade and various associations value his insights to the “why’s”, instead of the simple “what’s”, of market events.
Doug is also a frequent Industry speaker for the following groups: Health Distribution Management Association, National Association of Chain Drug Stores, Food Marketing Institute, National Council of Prescription Drug Programs, Pharmaceutical Care Management Association, National Community Pharmacist Association, International Federation of Pharmaceutical Wholesalers, Generics Pharmaceutical Association, BIO, AMCP, HIGPA and many others. Doug is also a member of the Editorial Advisory Board of HealthCare Distributor magazine and the Environmental Scanning Panel of HDMA. Doug was honored with the 2004 HDMA NEXUS Award for lifetime achievement and received IMS’s prestigious Summit award in 2003.
Prior to IMS HEALTH, Doug was at Nielsen Market Research for sixteen years in various sales and marketing capacities. A native of Illinois, Doug received a BA degree from DePauw University in Greencastle, Indiana, and an MBA in Management from Fairleigh Dickinson University in New Jersey.
JOSEPH METRO, Partner, Reed Smith
Joseph has focused on the reimbursement, regulatory, and fraud and abuse issues facing health care manufacturers and providers. He frequently provides analysis and counseling on behalf of manufacturers and providers on a broad variety of regulatory issues including: the Medicaid drug rebate statute, the Veterans Health Care Act’s drug pricing standards, the federal anti-kickback statute, and other state and federal laws relating to the promotion of prescription drugs and medical devices.
Joseph counsels providers and manufacturers on other regulatory matters, including state and federal health reform proposals (including Medicaid waivers), Medicare/Medicaid coverage and reimbursement matters, long term care hospital exemptions from the Medicare prospective payment system, the nursing home reforms of OBRA 1987, Medicare/Medicaid accounts receivable financing program. This likewise includes development and implementation of compliance programs, investigations and litigation under the False Claims Act, as well as commercial and strategic transactions.
SWATI ABBOTT, President, MEDai, Inc.
Ms. Abbott is President of MEDai, Inc. the industry leader in predictive analytics. As President, Ms. Abbott provides leadership to position the company at the forefront of the healthcare industry. Ms. Abbott develops strategic plans to advance the company's mission and objectives and to promote revenue, profitability and growth as an organization.
Prior to her role as President, Swati served as MEDai’s Senior Vice President. As Senior Vice President, she was responsible for managing pricing, joint marketing ventures, sales and establishing key alliances to ensure that MEDai solutions meet the critical needs of their clients, including hospitals, payers, and IPAs. During her tenure at MEDai she has secured more than ten million in revenue, negotiated major contracts with strategic partners in the payer market, and has become a regular speaker in the predictive modeling/care management circuit. Swati first joined MEDai as Vice President of Business Development in 2004 bringing with her a decade of expertise in healthcare software both in the provider and payer market segments.
Prior to MEDai Ms. Abbott held the title of Managing Director for the Medical Management Strategic Business Unit at ViPS, Ms. Abbott’s focus was to lead and provide strategic solutions for the healthcare payer clients for medical management data warehousing and HEDIS reporting. She also held the title of Director, Product Management, Services and IT of HealthObjects Corporation in Baltimore, MD. As a start up company her role at HealthObjects focused on working with beta customers, managing product releases, and identifying problems/gaps with the product and proactively resolving them. Prior to that, Ms Abbott was involved in leading SoftMed Systems, Inc to create and provide solutions for hospitals and IDNs in the key areas of medical chart abstraction, QA, UM, Risk Management, and regulatory reporting.
Ms. Abbott holds a M.S. in Computer Science and a B. S. in Physics from Delhi University.
YVONNE SOUTHWELL, Vice President, Clinical Affairs, CVS Caremark
Yvonne P. Southwell is Vice President of Clinical Affairs and is responsible for supporting clinical initiatives to ensure that programs and activities align with CVS Caremark’s clinical strategic goals. She has responsibility for the Formulary Administration area, managing formularies and drug lists for the Commercial and Medicare business, serves in a clinical oversight role and supports clinical product development.
A registered pharmacist, Ms. Southwell joined the company in 1989, when the division was an operating unit of Baxter Healthcare Corporation. Prior to her tenure with Baxter, she worked in both the hospital and retail pharmacy environments. She also served as a consultant for long-term care facilities.
Ms. Southwell's professional affiliations and activities include the Academy of Managed Care Pharmacy, the American Society of Health-System Pharmacists, and the American Society of Consultant Pharmacists. In addition, she serves on the Dean’s Advisory Council at Midwestern University College of Pharmacy, numerous clinical advisory and editorial boards and has supported several clinical publications.
Ms. Southwell received her Bachelor of Science degree in Chemistry and Biology from Valparaiso University and her Bachelor of Science degree in Pharmacy from the State University of New York at Buffalo. She has attended executive programs at the J.L. Kellogg Graduate School of Management at Northwestern University; the Johnson Graduate School of Management at Cornell University; and the Leonard Davis Institute of Health Economics at the Wharton School of the University of Pennsylvania.
KATHLEEN VIESON, Vice President, Director of Clinical Drug References
Kathleen Vieson, PharmD, BCOP, Kathy received her BS degree from The Ohio State University in 1989. Following completion of a General Residency at the University of Cincinnati Hospitals, Kathy received her Doctor of Pharmacy degree, with high distinction, from the University of Kentucky. Kathy then completed a specialty oncology residency at the Pittsburgh Cancer Institute at the University of Pittsburgh. In 1993, Kathy accepted a position at the H. Lee Moffitt Cancer Center as a Clinical Pharmacy Specialist. While at Moffitt Cancer Center Kathy served as the pharmacy liaison for the Leukemia/Lymphoma Program, Preceptor for the Specialty Oncology Residency program and for pharmacy students from University of Florida, NOVA Southeastern, and Creighton School of Pharmacy. In addition, she has been the Director of the Oncology Pharmacy Specialty Residency and Oncology Team Leader at Moffitt Cancer Center. In 1998, Kathy came to Gold Standard Inc. as Specialty Editor for Oncology, Pain Management, and Biotechnology products. In 2002, Kathy was promoted to Managing Editor for Product Information. In 2004, Kathy joined the Senior Management Team as the Vice President of Drug Product Data. In 2006, Kathy accepted the position of Vice President, Director Clinical References.
KAY MORGAN, Senior Vice President of Drug Products and Industry Standards Research and Compliance, Gold Standard Inc., an Elsevier company
Kay Morgan has served as the Senior Vice President of Drug Products and Industry Standards Research and Compliance for Gold Standard, an Elsevier company, since December 2007. Ms. Morgan’s responsibilities include reviewing existing and new Gold Standard products for compliance with industry standards established by organizations such as the National Council of Prescription Drug Programs (NCPDP), Health Level 7 (HL7), Health Information Technology Standards Panel (HITSP), Office of the National Coordinator for Health Information Technology (ONCHIT), American Health Information Community (AHIC) and the National Library of Science’s RxNorm. Kay’s expansive knowledge of the industry and the standard setting organizations ensures that Gold Standard/Elsevier products comply with industry standards to promote interoperability.
Previously, Ms. Morgan served Gold Standard as Vice President, Drug Product Pricing since July 2005. Prior to joining Gold Standard, Kay was the Manager of Product Knowledge Base Services with First DataBank, where she managed the U.S. pricing file, a component of the National Drug Data File. Kay previously held several positions with Abbott Laboratories, including Manager of Trade Relations and Third Party Payers, as well as Manager of Product Information. Ms. Morgan is presently a Work Group Co-Chair for the National Council of Prescription Drug Programs (NCPDP) and a former member of the NCPDP Board of Trustees. Ms. Morgan received her Bachelor of Science in Pharmacy from the University of Missouri, where she is an active participant of the Dean’s Advisory Council.
RICHARD FOSTER, Vice President, Marketing, Mutual Pharmaceuticals/AR Scientific
Mr. Foster has served as the Vice President of Marketing for Mutual Pharmaceuticals/AR Scientific since August 2005. He has extensive experience in both the generic and brand pharmaceutical industries, as well as in retail pharmacy. Mr. Foster has held positions from Director to Vice President of Marketing at Teva Pharmaceutical Industries and Watson Pharmaceuticals, Inc., in which he managed various departments from product management, pricing, product selection, and advertising. At Schering-Plough, Mr. Foster worked as a National Field Sales Manager in their Kenilworth Division, where he was responsible for marketing programs, sales training, managed care contracting and sales management for the flex-time sales force. Previously, at Thrift Drug, Inc., Mr. Foster gained retail pharmacy experience in his various purchasing positions. He joins us at Gold Standard Technology Summit to provide his personal, expansive knowledge of drug information industry issues, independent of his employment with Mutual/AR.
MICHAEL PODGURSKI, Vice President of Pharmacy Services, Rite Aid Corporation
Michael Podgurski is currently Vice President of Pharmacy Services, where he manages all state legislative initiatives, Boards of Pharmacy issues, regulations and all licensing matters for more than 5,100 pharmacies in 31 states and the District of Columbia. Previously, he was Vice President of Pharmacy Operations for Rite Aid Corporation, where he was responsible not only for the day-to-day operations of all Rite Aid pharmacies, but also oversaw all technology initiatives, which included pharmacy systems, design, workflow, automation and e-prescribing.
Michael has 35 years of experience in the retail drug industry, which includes Business Re-engineering, Information Systems, Third Party Administration and Pharmacy Operations.
Michael received a BS in Pharmacy from West Virginia University in 1972, is a member of APhA, NACDS, NCPA, ASAP, and is currently Chairman of the Pennsylvania Board of Pharmacy.
MARY J. RYAN, Vice President, Pharmacy Regulatory Group, Medco Health Solutions, Inc.
Ms. Ryan currently serves as Vice President of Medco’s Pharmacy Regulatory Group, where she is responsible for interface with various regulatory agencies, including state boards of pharmacy, and focuses primarily on the introduction of technology in pharmacy, such as automated dispensing and e-prescribing. Her duties include rule review and official comment, oral testimony and developing appropriate professional contacts; her staff concentrates on regulatory review, standards compliance and licensing functions.
Ms. Ryan’s previous positions include Vice President of Operations Planning, where her staff interfaced with clients on technological solutions associated with prescription benefit management; Vice President/General Manager, PAID Prescriptions, where her staff handled claims processing (including real-time claims processing logic) and help desk functions; and Director of Claims Processing.
Ms. Ryan earned her BS in Pharmacy from the University of Arizona, and her MBA from the Arizona State University Executives Program. Her professional affiliations include the Academy of Managed Care Pharmacy (AMCP), where she serves as Chair of the Legislative and Regulatory Action Committee, WEDI Board of Directors and the National Advisory Board, University of Arizona College of Pharmacy. She is also a member of the National Council for Prescription Drug Programs (NCPDP) and the American Pharmacists Association (APhA).
RUEY TU, Director, Market Access, Pricing and Reimbursement, Abbott International Marketing
Liang-Ruey Tu is the General Manager Market Access, Pricing and Reimbursement for Abbott International. Primary responsibilities include the development of global pricing, market access tools and reimbursement strategies in international markets for pharmaceuticals. Ruey is also the co-chair for the Market Access, Developed Countries (MADC) sub committee of PhRMA, the pharmaceutical trade organization. He has been in his current role for over three years and has been at Abbott Laboratories for approximately 14 years.
Previously positions include:
- Director of Public Health Policy and Reimbursement for Abbott U.S.
- Senior Marketing Manager for Managed Care National Accounts
- Marketing Manger Managed Care Regional Accounts
- Manager Strategic Pricing and Contracting
- Senior Financial Analyst Managed Care
Ruey’s U.S. experiences include marketing/market access and contracting for a variety of managed care customers including PBMs, HMOs, Long Term Care, VA/DoD, and Medicaid. In addition, he supported market access strategies for the Medicare Demonstration Project as part of the Medicare Modernization Act of 2003.
After receiving his M.B.A. from the University of Michigan Ruey joined Searle Pharmaceuticals before moving to Abbott. Ruey has both a BS and MS in Chemical Engineering from the University of Michigan.
Meeting schedule and sessions are subject to changes and updates. Please refer to this website for additional information.
Back to GSTS meeting homepage |
 |
